Cardioprotective Efficacy of a Novel Antioxidant Mix VitaePro Against Ex Vivo Myocardial Ischemia-Reperfusion Injury

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 281-286

  Adluri, Ram Sudheer ^a   Thirunavukkarasu, Mahesh ^a   Zhan, Lijun ^a   Maulik, Nilanjana ^a   Svennevig, Katja ^d   Bagchi, Manashi ^c   Maulik, Gautam ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NutriToday   (United States)

^d Vitas as   (Norway)

Author keywords

Apoptosis; Ischemia reperfusion; Oxidative stress; VitaePro; Vitamin E

Indexed keywords

ANIMALIA; RATTUS;

ANTIOXIDANT; ASTAXANTHIN; CARDIOTONIC AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHOPHYLL; ZEAXANTHIN;

ANIMAL; APOPTOSIS; ARTICLE; DRUG COMBINATION; DRUG EFFECT; HEART; HEART MUSCLE CELL; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOTONIC AGENTS; DRUG COMBINATIONS; HEART; LUTEIN; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; XANTHOPHYLLS;

EID: 84886584338     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9300-7     Document Type: Article

References (19)

1. Moens, A. L., Claeys, M. J., Timmermans, J. P., & Vrints, C. J. (2005). Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. International Journal of Cardiology, 100, 179-190.
2. Saeed, S. A., Waqar, M. A., Zubairi, A. J., Bhurgri, H., Khan, A., Gowani, S. A., et al. (2005). Myocardial ischaemia and reperfusion injury: Reactive oxygen species and the role of neutrophil. Journal of College of Physicians and Surgeons Pakistan, 15, 507-514.
3. Zweier, J. L., & Talukder, M. A. (2006). The role of oxidants and free radicals in reperfusion injury. Cardiovascular Research, 70, 181-190.
4. Dhalla, N. S., Elmoselhi, A. B., Hata, T., & Makino, N. (2000). Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovascular Research, 47, 446-456.
5. Zhang, X., Klein, A. L., Alberle, N. S., Norby, F. L., Ren, B. H., Duan, J., et al. (2003). Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. Journal of Molecular and Cellular Cardiology, 35, 645-652.
6. Osganian, S. K., Stampfer, M. J., Rimm, E., Spiegelman, D., Manson, J. E., & Willett, W. C. (2003). Dietary carotenoids and risk of coronary artery disease in women. American Journal of Clinical Nutrition, 77, 1390-1399.
7. Otton, R., Marin, D. P., Bolin, A. P., Santos, R. D., Polotow, T. G., Sampaio, S. C., et al. (2010). Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats. Chemico-Biological Interactions, 186, 306-315.
8. Higuera-Ciapara, I., Felix-Valenzuela, L., & Goycoolea, F. M. (2006). Astaxanthin: A review of its chemistry and applications. Critical Reviews in Food Science and Nutrition, 46, 185-196.
9. Hussein, G., Nakagawa, T., Goto, H., Shimada, Y., Matsumoto, K., Sankawa, U., et al. (2007). Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sciences, 80, 522-529.
10. Voutilainen, S., Nurmi, T., Mursu, J., & Rissanen, T. H. (2006). Carotenoids and cardiovascular health. American Journal of Clinical Nutrition, 83, 1265-1271.
11. Chamberlain, S. M., Hall, J. D., Patel, J., Lee, J. R., Marcus, D. M., Sridhar, S., et al. (2009). Protective effects of the carotenoid zeaxanthin in experimental nonalcoholic steatohepatitis. Digestive Diseases and Sciences, 54, 1460-1464.
12. Arnal, E., Miranda, M., Barcia, J., Bosch-Morell, F., & Romero, F. J. (2010). Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Neuroscience, 166, 271-278.
13. Thirunavukkarasu, M., Penumathsa, S. V., Koneru, S., Juhasz, B., Zhan, L., Otani, H., et al. (2007). Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radical Biology and Medicine, 43, 720-729.
14. Penumathsa, S. V., Thirunavukkarasu, M., Samuel, S. M., Zhan, L., Maulik, G., Bagchi, M., et al. (2009). Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochimica et Biophysica Acta, 1792, 39-48.
15. Niehaus, W. G., Jr., & Samuelsson, B. (1968). Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. European Journal of Biochemistry, 6, 126-130.
16. Mohan, I. K., Khan, M., Wisel, S., Selvendiran, K., Sridhar, A., Carnes, C. A., et al. (2009). Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction. American Journal of Physiology Heart and Circulatory Physiology, 296, H140-H151.
17. Thirunavukkarasu, M., Penumathsa, S. V., Samuel, S. M., Akita, Y., Zhan, L., Bertelli, A. A., et al. (2008). White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt/FOXO3a/NFkappaB survival pathway. Journal of Agricultural and Food Chemistry, 56, 6733-6739.
18. Foadoddini, M., Esmailidehaj, M., Mehrani, H., Sadraei, S. H., Golmanesh, L., Wahhabaghai, H., et al. (2010). Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. European Journal of Cardio-Thoracic Surgery, 39, 233-240.
19. Ribaya-Mercado, J. D., & Blumberg, J. B. (2004). Lutein and zeaxanthin and their potential roles in disease prevention. Journal of the American College of Nutrition, 23, 567-587.